USC reveals 8 foundational partners for Virtual Care Center

The University of Southern California (USC) Center for Body Computing (CBC), the digital health innovation accelerator for the Keck Medicine of USC medical enterprise, has announced eight foundational partners for its Virtual Care Clinic (VCC).  The disruptive digital healthcare model uses mobile apps, wearable sensors, virtual human healthcare providers, augmented and virtual reality (AR/VR), data collection, analytics and artificial intelligence using digital communication tools for a seamless, integrated system where patients can access medical care and content from any location. The VCC, housed at the USC Institute of Creative Technologies (ICT), is located in Playa Vista, which is in Los Angeles’ digital zone known as Silicon Beach. The VCC intends to harness cutting-edge technologies and creative solutions developed at ICT to extend Keck Medicine of USC experts to anyone with a smartphone, according to information on the organization’s website. Dr. Evidence, IMS Health, Karten Design, Medable, Planet Grande, Proteus Digital Medicine and VSP Global are the foundational partners along with ICT. “Our Virtual Care Clinic is not only the democratization of healthcare allowing anyone access to our medical experts without leaving their home, but it also capitalizes on the promise that digital health is supposed to offer,” said Leslie Saxon, MD. “Because we have worked in collaboration with our VCC partners and our medical experts, this healthcare model will empower patients, improve quality outcomes with more precision medicine analytics and diagnosis and enhance the physician-patient relationship by creating a contextualized experience and seamless communication that puts the patient in the driver seat of their own healthcare experience and outcomes.”   
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.